Company: VERA
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029969
Chunk: 139

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 139
---
 matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

/s/ KPMG LLP

We have served as the Company’s auditor since 2018.

San Francisco, CaliforniaFebruary 28, 2025

102

VERA THERAPEUTICS, INC. 

Balance Sheets 

(in thousands, except share and per share amounts) 

    December 31,

    2024

    2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    92,646

    $
    45,681

    Marketable securities

    548,206

    115,035

    Prepaid expenses and other assets, current

    10,366

    11,307

    Total current assets

    651,218

    172,023

    Property and equipment, net

    960

    92

    Operating lease right-of-use assets

    3,372

    2,949

    Prepaid expenses and other assets, noncurrent

    131

    482

    Total assets
     
    $
    655,681

    $
    175,546

    Liabilities and stockholders’ equity

    Current liabilities:

    Accounts payable
     
    $
    7,665

    $
    11,118

    Operating lease liabilities

    1,483

    2,436

    Accrued expenses and other liabilities, current

    16,223

    8,749

    Total current liabilities

    25,371

    22,303

    Long-term debt

    50,687

    49,877

    Operating lease liabilities, noncurrent

    2,468

    1,395

    Accrued expenses and other liabilities, noncurrent

    —

    286

    Total liabilities

    78,526

    73,861

    Stockholders’ equity

    Preferred stock, $0.001 par value; 10,000,000 authorized   as of December 31, 2024 and 2023; no shares